Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,826 | -26,294 | -16,364 | -9,721 | -4,209 |
| Depreciation Amortization | 64 | 140 | 90 | 49 | 22 |
| Other Working Capital | 1,863 | -481 | 535 | 21 | -665 |
| Other Operating Activity | 3,974 | 2,890 | 1,022 | 512 | 174 |
| Operating Cash Flow | $-8,925 | $-23,745 | $-14,717 | $-9,139 | $-4,678 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -239 | -645 | -540 | -300 | -60 |
| Investing Cash Flow | $-239 | $-645 | $-540 | $-300 | $-60 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -9 | -9 | -9 | -4 |
| Common Stock Issued | 238 | 181,734 | 513 | 536 | 533 |
| Other Financing Activity | 0 | 129,623 | 312,352 | 128,892 | 129,623 |
| Financing Cash Flow | $238 | $311,348 | $312,856 | $129,419 | $130,152 |
| Beginning Cash Position | 302,425 | 15,467 | 15,467 | 15,467 | 15,467 |
| End Cash Position | 293,499 | 302,425 | 313,066 | 135,447 | 140,881 |
| Net Cash Flow | $-8,926 | $286,958 | $297,599 | $119,980 | $125,414 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,925 | -23,745 | -14,717 | -9,139 | -4,678 |
| Capital Expenditure | -239 | -661 | -556 | -300 | -60 |
| Free Cash Flow | -9,164 | -24,406 | -15,273 | -9,439 | -4,738 |